{ "items": [ "\n\n
A feasibility and efficacy trial evaluating a suturing augmentation device for rotator cuff repairs
\n \n\n \n \nMore information coming soon
\n \n\n \n \nThis NIHR Programme aims to provide high quality evidence to establish best practice for the management of this common sinus disease. The large multi-disciplinary MACRO research team have come together to tackle the disease from many different aspects \u2013 across primary and secondary care, and from a clinical, economic and patient perspective.
\n \n\n \n \nMore information coming soon.
\n \n\n \n \nThis is an international study investigating wearable devices for distal arm functionality rehabilitation
\n \n\n \n \nDelivering personalised care in the management of exacerbations of chronic obstructive pulmonary disease: A multi-centre randomised clinical trial.
\n \n\n \n \nMore information coming soon
\n \n\n \n \nThe NINJA study is a pilot study which will assess whether a study that looks at whether nail plates should be discarded or replaced after nail bed injury in children is feasible in the NHS.
\n \n\n \n \nCEeDD: A phase I / II study to investigate the safety and feasibility of CavitationEnhanced Drug Delivery to solid tumours by co\u2010administration of sonosensitive particles and application of extracorporeal ultrasound
\n \n\n \n \nAnti-neutrophil cytoplasm antibody associated vasculitis treated with Interleukin-2 (ANVIL) therapy: proof of concept study.
\n \n\n \n \nThis is a single-centre study in those with high-risk prostate cancer.
\n \n\n \n \nThis is a single centre observational study to evaluate changes in functional images (MRI, Perfusion - CT, & FDG PET) after treatment with chemoradiotherapy.
\n \n\n \n \nThis is a two part, Phase 1 open label dose escalation and expansion study to assess safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours.
\n \n\n \n \nMONITOR PsA - Multicentre ObservatioNal Initiative in Treat to target Outcomes in Psoriatic Arthritis
\n \n\n \n \nThis NIHR Programme aims to provide high quality evidence to establish best practice for the management of this common sinus disease. The large multi-disciplinary MACRO research team have come together to tackle the disease from many different aspects \u2013 across primary and secondary care, and from a clinical, economic and patient perspective
\n \n\n \n \nThis is a multi-centre, open label, 2 stage trial in patients with oesophageal cancer
\n \n\n \n \nThis is a study to assess cell therapy as a treatment to prevent kidney transplant rejection. Patients will be randomly assigned to either receive standard medication after transplant or a modified regimen including the cell product.
\n \n\n \n \n